1. Rituximab

   Case report 16 October 2021 Pages: 351 - 351

2. Rituximab

   Case report 16 October 2021 Pages: 352 - 352

3. Rituximab

   Case report 16 October 2021 Pages: 353 - 353

4. Rivoceranib

   Case report 16 October 2021 Pages: 354 - 354

5. Rocuronium bromide

   Case report 16 October 2021 Pages: 355 - 355

6. Rocuronium bromide/sugammadex

   Case report 16 October 2021 Pages: 356 - 356

7. Rocuronium-bromide

   Case report 16 October 2021 Pages: 357 - 357

8. Ropivacaine

   Case report 16 October 2021 Pages: 358 - 358

9. Ruxolitinib

   Case report 16 October 2021 Pages: 359 - 359

10. Safinamide

    Case report 16 October 2021 Pages: 360 - 360

11. SARS-COV-2 vaccine inactivated Sinovac Biotech

    Case report 16 October 2021 Pages: 361 - 361

12. Scutellaria-baicalensis

    Case report 16 October 2021 Pages: 362 - 362

13. Sertraline

    Case report 16 October 2021 Pages: 363 - 363

14. Sintilimab

    Case report 16 October 2021 Pages: 364 - 364

15. Sirolimus

    Case report 16 October 2021 Pages: 365 - 365

16. Sorafenib

    Case report 16 October 2021 Pages: 366 - 366

17. Sorafenib

    Case report 16 October 2021 Pages: 367 - 367

18. Sulphan blue

    Case report 16 October 2021 Pages: 368 - 368

19. Sulphan-blue

    Case report 16 October 2021 Pages: 369 - 369

20. Suxamethonium-chloride

    Case report 16 October 2021 Pages: 370 - 370

21. Suxamethonium-chloride

    Case report 16 October 2021 Pages: 371 - 371

22. Tacrolimus

    Case report 16 October 2021 Pages: 372 - 372

23. Tacrolimus/tigecycline

    Case report 16 October 2021 Pages: 373 - 373

24. Temocillin

    Case report 16 October 2021 Pages: 374 - 374

25. Tetrabenazine

    Case report 16 October 2021 Pages: 375 - 375

26. Thiamazole

    Case report 16 October 2021 Pages: 376 - 376

27. Thiamine/general-anaesthetics

    Case report 16 October 2021 Pages: 377 - 377

28. Thioctic acid/unithiol

    Case report 16 October 2021 Pages: 378 - 378

29. Tirofiban

    Case report 16 October 2021 Pages: 379 - 379

30. Tofacitinib

    Case report 16 October 2021 Pages: 380 - 380

31. Tozinameran

    Case report 16 October 2021 Pages: 381 - 381

32. Tozinameran

    Case report 16 October 2021 Pages: 382 - 382

33. Tozinameran

    Case report 16 October 2021 Pages: 383 - 383

34. Tranexamic-acid

    Case report 16 October 2021 Pages: 384 - 384

35. Trastuzumab

    Case report 16 October 2021 Pages: 385 - 385

36. Trazodone/benzodiazepines/antipsychotics

    Case report 16 October 2021 Pages: 386 - 386

37. V-503

    Case report 16 October 2021 Pages: 387 - 387

38. Valbenazine

    Case report 16 October 2021 Pages: 388 - 388

39. Valproic acid

    Case report 16 October 2021 Pages: 389 - 389

40. Vedolizumab

    Case report 16 October 2021 Pages: 390 - 390

41. Venetoclax

    Case report 16 October 2021 Pages: 391 - 391

42. Vigabatrin

    Case report 16 October 2021 Pages: 392 - 392

43. Vincristine

    Case report 16 October 2021 Pages: 393 - 393

44. Vincristine

    Case report 16 October 2021 Pages: 394 - 394

45. Voriconazole

    Case report 16 October 2021 Pages: 395 - 395

46. Vortioxetine/quetiapine

    Case report 16 October 2021 Pages: 396 - 396

47. Warfarin

    Case report 16 October 2021 Pages: 397 - 397

48. Warfarin

    Case report 16 October 2021 Pages: 398 - 398

49. Warfarin

    Case report 16 October 2021 Pages: 399 - 399

50. Non-serious case reports

    News item 16 October 2021 Pages: 400 - 400